This is an NIH research grant to continue the CaRe-T1D consortium, which studies cardiovascular disease in people with type 1 diabetes. It is for research organizations — universities, nonprofits, and research-oriented businesses — that can contribute to a collaborative biomedical research effort, not for companies looking for general business funding. If you are not running or partnering on type 1 diabetes or cardiovascular research, do not bother applying.
| Industry | Estimated fit |
|---|---|
| Healthcare & BiotechMatches your industry (clinical) | 72 |
| Arts & CultureLimit: Not clearly about your industry or what you need funding for; check the… | 54 |
| Education & TrainingLimit: Not clearly about your industry or what you need funding for; check the… | 54 |
| Energy & Clean TechLimit: Nothing in this notice points to energy & clean tech | 54 |
| Environment & ConservationLimit: Nothing in this notice points to environment & conservation | 54 |
| Finance & BankingLimit: Not clearly about your industry or what you need funding for; check the… | 54 |
| Industry | Estimated fit |
|---|---|
| Food & BeverageLimit: Not clearly about your industry or what you need funding for; check the… | 54 |
| Housing & Real EstateLimit: Nothing in this notice points to housing & real estate | 54 |
| Social Services & NonprofitLimit: Not clearly about your industry or what you need funding for; check the… | 54 |
| Technology & SoftwareLimit: Nothing in this notice points to technology & software | 54 |
| Agriculture & FarmingLimit: Nothing in this notice points to agriculture & farming | 53 |
| ManufacturingLimit: Nothing in this notice points to manufacturing | 53 |
| Transportation & LogisticsLimit: Nothing in this notice points to transportation & logistics | 53 |
| Construction & InfrastructureLimit: Nothing in this notice points to construction & infrastructure | 51 |
| Retail & E-CommerceLimit: Nothing in this notice points to retail & e-commerce | 51 |
These are our matcher’s estimates for a typical business in each industry. A real match depends on your size, your state and what you need the money for — check your own fit.
NIH U01 cooperative agreement to continue the CaRe-T1D consortium, supporting collaborative research on cardiovascular disease mechanisms in type 1 diabetes. Eligible applicants include states, local governments, tribes, nonprofits, higher education institutions, and for-profit organizations including small businesses; foreign entities are not eligible.
The NIH Cardiovascular Repository for Type 1 Diabetes (CaRe-T1D) was created to improve research on type 1 diabetes (T1D) and cardiovascular disease (CVD). Cardiovascular complications remain the top cause of death among people with T1D and greatly shorten lifespan. The mechanisms underlying atherosclerosis, cardiomyopathy, endothelial dysfunction, and cardiac autonomic neuropathy in T1D remain poorly understood. While managing traditional risk factors—such as high blood glucose, high blood pressure, and elevated cholesterol lower cardiovascular risk, a significant residual risk remains even with optimal control. In addition to atherosclerosis, both diastolic and systolic diabetic cardiomyopathy play a major role in morbidity and mortality among these patients. Currently, no therapies are specifically approved to prevent or treat these common and severe cardiovascular issues in T1D. The purpose of this NOFO is to promote collaborative and interdisciplinary research aimed at enhancing the understanding of the development of CVD in individuals with T1D and the differences with CVD in T1D by continuing the efforts of the CaRe-T1D consortium.This NOFO is associated with the Special Diabetes Program (https://www.niddk.nih.gov/about-niddk/research-areas/diabetes/type-1-diabetes-special-statutory-funding-program/about-special-diabetes-program) which funds research on the prevention, treatment, and cure of type 1 diabetes and its complications, including unique, innovative, and collaborative research consortia and clinical trials networks.
Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Topics
Open opportunities funding similar work, from the same funder or in the same place.
NIH BRAIN Initiative grants to develop tools and computational models for high-resolution, synchronous measurement of complex behaviors alongside neural activity in humans and other species. Eligible applicants include…
NIH/NCI K99/R00 career-development award for early-stage postdoctoral researchers (with research or clinical doctorates) transitioning to independent tenure-track faculty positions; requires the candidate to lead an…
NIH/NCI UH3 cooperative agreement to clinically validate established molecular, cellular, or imaging biomarker assays for cancer detection, diagnosis, prognosis, monitoring, or treatment response using specimens from…
NIH/NCI K99/R00 award for early-stage postdoctoral researchers (with research or clinical doctorates) transitioning to independent faculty careers. The applicant is typically the sponsoring institution; eligible…
NIH/NCI cooperative agreement (UH2/UH3) funding validation of molecular, cellular, and imaging biomarker assays for cancer detection, diagnosis, prognosis, monitoring, and treatment response. Open to universities,…
NIH/NCI program funding revision applications to adapt and clinically validate molecular, cellular, or imaging biomarker assays for cancer detection, diagnosis, prognosis, monitoring, and treatment response prediction.…